Published in J Exp Med on March 01, 1973
Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med (1976) 5.50
Selective roles of thymus-derived lymphocytes in the antibody response. I. Differential suppressive effect of carrier-primed T cells on hapten-specific IgM and IgG antibody responses. J Exp Med (1974) 2.50
Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. II. Evidence for separate stimulatory and inhibitory cells. J Exp Med (1973) 2.33
Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes. J Exp Med (1974) 2.26
The nature of immunosuppression in Trypanosoma brucei infections in mice. II. The role of the T and B lymphocytes. Immunology (1974) 2.23
Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. J Clin Invest (1978) 1.93
Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells. J Exp Med (1974) 1.77
Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved. Infect Immun (1978) 1.58
Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1978) 1.54
Influence of dietary restriction on immunologic function and renal disease in (NZB x NZW) F1 mice. Proc Natl Acad Sci U S A (1978) 1.52
Loss of suppressor T cells in adult NZB/NZW mice. J Exp Med (1976) 1.52
Dengue virus-induced thymus-derived suppressor cells in the spleen of mice. Immunology (1979) 1.50
Alteration of clearance function by group A streptococcal pyrogenic exotoxin and its relation to suppression of the antibody response. Infect Immun (1978) 1.40
Separation of helper and suppressor T lymphocytes. II. Ly phenotypes and lack of DNA synthesis requirement for the generation of concanavalin A helper and suppressor cells. J Exp Med (1977) 1.39
Suppression of in vitro antibody synthesis by immunoglobulin-binding factor. J Exp Med (1975) 1.37
Functional characteristics of Peyer's patch lymphoid cells. II. Lipopolysaccharide is thymus dependent. J Exp Med (1974) 1.37
Separation of helper and suppressor T lymphocytes on a ficoll velocity sedimentation gradient. J Exp Med (1976) 1.36
Ly phenotype and mechanism of action of mouse neonatal suppressor T cells. J Exp Med (1977) 1.33
Studies on delayed hypersensitivity in mice. III. Evidence for suppressive regulatory T1-cell population in delayed hypersensitivity. J Exp Med (1977) 1.31
Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems. J Clin Invest (1979) 1.24
Changes in suppressor mechanisms during postnatal development in mice. J Exp Med (1978) 1.22
Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease. J Clin Invest (1978) 1.16
The use of concanavalin A to study the immunoregulation of human T cells. Clin Exp Immunol (1981) 1.15
Thymus-dependent lymphocytes of dengue virus-infected mice spleens mediate suppression through prostaglandin. Immunology (1981) 1.10
Cyclophosphamide eliminates suppressor T cells in age-associated central regulation of delayed hypersensitivity in mice. J Exp Med (1979) 1.07
Dual regulatory role of the thymus in the maturation of immune response in the rabbit. J Exp Med (1974) 1.07
In vitro studies of the rabbit immune system. V. Suppressor T cells activated by concanavalin A block the proliferation, not the induction of antierythrocyte plaque-forming cells. J Exp Med (1976) 1.05
Induction of human antigen-specific and non-specific helper factors in vitro. Clin Exp Immunol (1979) 1.03
The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions. J Exp Med (1978) 1.03
Activation of murine T-suppressor lymphocytes by group A streptococcal and staphylococcal pyurogenic exotoxins. Infect Immun (1980) 1.03
Animal models of human systemic lupus erythematosus. Yale J Biol Med (1979) 1.02
Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A. Infect Immun (1984) 1.01
Evidence for the synthesis and release of strongly immunosuppressive, noncytotoxic substances by Streptococcus intermedius. J Clin Invest (1979) 1.01
Variables which affect suppression of the immune response induced by Pseudomonas aeruginosa exotoxin A. Infect Immun (1986) 1.00
Bacterial lipopolysaccharide activates suppressor B lymphocytes. Proc Natl Acad Sci U S A (1979) 1.00
Helper T cells are required for the polyclonal stimulation of cytotoxic T cells by concanavalin A. J Exp Med (1977) 0.98
Suppression of DNA synthesis by Con A-activated human lymphocytes: Stimulation by con A bound to non-T cells unless removed after activation. Clin Exp Immunol (1977) 0.97
Immunological defects in SJL mice. Immunology (1986) 0.97
Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm. Immunology (2008) 0.97
Effect of irradiation on the precursor, activated and memory suppressor T cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Immunology (1984) 0.95
Induction and mode of action of suppressor cells generated against human gamma globulin. II. Effects of colchicine. J Exp Med (1979) 0.94
Suppression of IgE antibody production in SJL mice. III. Characterization of a suppressor substance extracted from normal SJL spleen cells. J Exp Med (1977) 0.92
In vitro X-ray irradiation of human peripheral blood T lymphocytes enhances suppressor function. Clin Exp Immunol (1983) 0.89
Regulation of the primary in vitro antibody response in human peripheral blood lymphocytes: different effects of mitogen-induced and spontaneous T suppressor cells. Clin Exp Immunol (1979) 0.88
Effect of colchicine on the antibody response. II. Demonstration of the inactivation of suppressor cell activities by colchicine. J Exp Med (1978) 0.88
Macrophages: modulators of immunity. Parke-Davis Award Lecture. Am J Pathol (1980) 0.88
Relative ability to provide help: an explanation for Con A-induced suppression. Clin Exp Immunol (1981) 0.88
Reactivity of anti-human brain serum with human lymphocytes. Am J Pathol (1977) 0.87
Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro. J Clin Invest (1983) 0.87
Regulatory T cells in CNS injury: the simple, the complex and the confused. Trends Mol Med (2011) 0.86
Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. New J Sci (2014) 0.85
Immunoregulation in experimental filariasis. IV. Induction of non-specific suppression following in vitro exposure of spleen cells from infected jirds to Brugia pahangi antigen. Immunology (1984) 0.85
T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review. Am J Pathol (1977) 0.84
Immunoregulation and anti-nuclear antibodies in mercury-induced glomerulopathy in the rat. Clin Exp Immunol (1981) 0.84
Hydrocortisone reverses the suppression of immunoglobulin synthesis by concanavalin A-activated spleen cell supernatants. Clin Exp Immunol (1982) 0.82
Antigen-induced suppression in man: non-specific suppression mediated via OKT8+ cells. Immunology (1984) 0.81
T-cell artificial focal triggering tools: linking surface interactions with cell response. PLoS One (2009) 0.81
Selective inhibition of functional lymphocyte subpopulations by ribavirin. Antimicrob Agents Chemother (1982) 0.81
Characteristics of suppressor factors generated from human mononuclear cells using concanavalin A and C-reactive protein. Clin Exp Immunol (1983) 0.78
Ovine concanavalin A-induced suppressor cells: generation, assay, age-related effects and re-evaluation of mechanism of suppression. Immunology (1985) 0.76
Neutralization of interleukin-10 from CD14(+) monocytes enhances gamma interferon production in peripheral blood mononuclear cells from Mycobacterium avium subsp. paratuberculosis-infected goats. Clin Vaccine Immunol (2009) 0.76
Effects of whole-body irradiation on neonatally thymectomized mice. Incidence of benign and malignant tumors. Am J Pathol (1978) 0.75
Prevention of autoimmune thyroiditis in T cell-depleted rats by injections of crude thyroid extract. Clin Exp Immunol (1977) 0.75
Suppression of polyclonal immunoglobulin biosynthesis by a soluble factor: T-cell dependent and T-cell independent mitogens. Immunology (1980) 0.75
Effects of mitogens for mouse B lymphocytes on chicken lymphoid cells. Immunology (1975) 0.75
Characterization of dextran-activated T-cell factors. Immunology (1976) 0.75
Antigenic competition between heterologous erythrocytes in mice. Immunological and histological studies exploring mechanisms of the antigenic competition. Immunology (1977) 0.75
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol (1972) 9.43
Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes. J Exp Med (1971) 4.89
Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity. J Exp Med (1972) 3.80
Reversible interaction of human lymphocytes with the mitogen concanavalin A. Exp Cell Res (1970) 3.08
Regulation of homocytotropic antibody formation in the rat. 3. Effect of thymectomy and splenectomy. J Immunol (1971) 2.61
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. J Immunol (1970) 2.59
Immune responses in vitro. IV. Suppression of primary M, G, and A plaque-forming cell responses in mouse spleen cell cultures by class-specific antibody to mouse immunoglobulins. J Exp Med (1972) 2.43
Frequency of antigen-sensitive cells to thymus-independent antigens. Cell Immunol (1971) 2.39
Enhanced immune responsiveness to a thymus-independent antigen early after adult thymectomy: evidence for short-lived inhibitory thymus-derived cells. Eur J Immunol (1972) 2.34
Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors. Cell Immunol (1970) 1.93
Biological expressions of lymphocyte activation : I. Effects of phytomitogens on antibody synthesis in vitro. J Exp Med (1973) 1.83
Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A. J Immunol (1972) 1.82
Activity of migration inhibitory factor in the absence of antigen. J Immunol (1972) 1.68
Immune response in vitro: independence of "activated" lymphoid cells. Science (1969) 1.52
Response of mouse T and B lymphocytes to sheep erythrocytes. Nat New Biol (1972) 1.45
The effect of immunologically induced lymphopenia on antibody formation. J Immunol (1969) 1.23
Studies of antibody formation in vitro and in lethally irradiated reconstituted mice. Evidence for an inhibitory function of thymus-derived cells. Scand J Immunol (1972) 1.10
Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). J Exp Med (1974) 5.55
Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes. J Exp Med (1971) 4.89
Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med (1971) 4.41
Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). J Immunol (1976) 3.64
Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures. J Immunol (1974) 3.27
Regulation by the H-2 gene complex of macrophage-lymphoid cell interactions in secondary antibody responses in vitro. J Exp Med (1976) 3.10
Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science (1989) 3.03
Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice. J Exp Med (1974) 3.01
Immune responses in vitro. I. Cellular requirements for the immune response by nonprimed and primed spleen cells in vitro. J Exp Med (1969) 2.84
Immune responses in vitro. IV. Suppression of primary M, G, and A plaque-forming cell responses in mouse spleen cell cultures by class-specific antibody to mouse immunoglobulins. J Exp Med (1972) 2.43
Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes. J Exp Med (1974) 2.26
Regulatory mechanisms in cell-mediated immune responses. III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions. J Exp Med (1976) 2.24
Regulatory mechanisms in cell-mediated immune responses. II. A genetically restricted suppressor of mixed lymphocyte reactions released by alloantigen-activated spleen cells. J Exp Med (1975) 2.18
Antigen presentation by major histocompatibility complex class I-B molecules. Annu Rev Immunol (1994) 1.86
Biological expressions of lymphocyte activation : I. Effects of phytomitogens on antibody synthesis in vitro. J Exp Med (1973) 1.83
Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells. J Exp Med (1974) 1.77
Functional maturation of thymic lymphocyte populations in vitro. J Exp Med (1972) 1.76
Regulation of immune responses by suppressor T cells. Tohoku J Exp Med (1976) 1.73
A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest (1993) 1.66
The stimulation of specific suppressor T cells in genetic non-responder mice by linear random copolymers of L-amino acids. Transplant Rev (1975) 1.64
Specialized role for a murine class I-b MHC molecule in prokaryotic host defenses. Science (1992) 1.57
Biological expressions of lymphocyte activation. IV. Concanavalin A-activated suppressor cells in mouse mixed lymphocyte reactions. J Immunol (1975) 1.54
RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.54
Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthritis Rheum (1973) 1.53
Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest (1972) 1.52
Immune response in vitro: independence of "activated" lymphoid cells. Science (1969) 1.52
Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol (1991) 1.50
Immune responses in vitro. X. Functions of macrophages. J Immunol (1974) 1.47
Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun (1993) 1.47
Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.47
Immune responses in vitro. II. Suppression of the immune response in vitro by specific antibody. J Exp Med (1969) 1.45
Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis (1971) 1.43
Immune responses in vitro. V. Suppression of M, G, and A plaque-forming cell responses in cultures of primed mouse spleen cells by class-specific antibody to mouse immunoglobulins. J Exp Med (1972) 1.40
Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect Immun (1994) 1.39
The immune response suppressed by specific antibody. Immunology (1969) 1.38
Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. J Immunol (1992) 1.35
Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta. J Exp Med (1990) 1.32
T and B cells that recognize the same antigen do not transcribe similar heavy chain variable region gene segments. J Exp Med (1983) 1.31
Mode of action of a soluble immune response suppressor (SIRS) produced by concanavalin a-activated spleen cells. J Immunol (1978) 1.30
Dissociation of the stimulatory activities of staphylococcal enterotoxins for T cells and monocytes. J Exp Med (1990) 1.29
Regulatory mechanisms in cell-mediated immune responses. IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes. J Exp Med (1976) 1.27
Immune responses in vitro. VI. Cell interactions in the development of primary IgM, IgG and IgA plaque-forming cell responses in vitro. Cell Immunol (1973) 1.27
Secondary antibody responses in vitro to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X nonresponder)F1 spleen cells stimulated by parental GAT-macrophages. J Exp Med (1977) 1.26
Immune responses in vitro. XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitro by alloantisera against leukocyte alloantigens. J Exp Med (1974) 1.24
Staphylococcal toxins bind to different sites on HLA-DR. J Immunol (1991) 1.21
Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. J Infect Dis (1985) 1.21
Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol (1976) 1.21
Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity. J Exp Med (1993) 1.20
Primary in vitro cytotoxic response of NZB spleen cells to Qa-1b-associated antigenic determinants. J Exp Med (1979) 1.19
Receptor diversity of insulin-specific T cell lines from C57BL (H-2b) mice. J Immunol (1987) 1.19
H-2-nonrestricted cytotoxic responses to an antigen encoded telomeric to H-2D. J Immunol (1979) 1.19
Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm. Immunogenetics (1988) 1.18
Mutation of the disulfide loop in staphylococcal enterotoxin A. Consequences for T cell recognition. J Immunol (1991) 1.17
Human immune responses to hapten-conjugated cells. I. Primary and secondary proliferative responses in vitro. J Exp Med (1978) 1.15
Specialized functions of major histocompatibility complex class I molecules. II. Hmt binds N-formylated peptides of mitochondrial and prokaryotic origin. J Exp Med (1991) 1.15
Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol Cell Biol (1994) 1.13
Regulatory mechanisms in immune responses to heterologous insulins. II. Suppressor T cell activation associated with nonresponsiveness in H-2b mice. J Exp Med (1984) 1.12
Characterization and distribution of insertion sequence IS1239 in Streptococcus pyogenes. Gene (1994) 1.11
Activation of a suppressor T-cell pathway by interferon. Proc Natl Acad Sci U S A (1982) 1.10
Purification and analysis of isoforms of soluble immune response suppressor (SIRS). J Immunol (1985) 1.09
Genetic restriction of macrophage-lymphocyte interactions in secondary antibody responses in vitro. Cold Spring Harb Symp Quant Biol (1977) 1.09
Regulatory mechanisms in cell-mediated immune responses. VII. Presence of I-C subregion determinants on mixed leukocyte reaction suppressor factor. J Exp Med (1979) 1.07
Three T cell hybridomas do not contain detectable heavy chain variable gene transcripts. J Exp Med (1983) 1.06
Modulation of immune responses by suppressor T cells. Fed Proc (1978) 1.05
Sequential effects of prostaglandins and interferon-gamma on differentiation of CD8+ suppressor cells. J Immunol (1987) 1.04
Soluble immune response suppressor (SIRS) inhibits microtubule function in vivo and microtubule assembly in vitro. J Immunol (1984) 1.04
Qa-1-associated antigens. I. Generation of H-2-nonrestricted cytotoxic T lymphocytes specific for determinants of the Qa-1 region. J Immunol (1979) 1.04
Mitochondria control expression of a murine cell surface antigen. Nature (1984) 1.03
Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun (1992) 1.01
The HLA complex and the pathogenesis of infectious diseases. J Infect Dis (1985) 1.01
Maternally transmitted antigen. Adv Immunol (1986) 1.00
Immunoglobulin receptors on B lymphocytes: shifts in immunoglobulin class during immune responses. Fed Proc (1973) 1.00
Antigen-specific suppressor T-cell activity in genetically restricted immune spleen cells. J Exp Med (1978) 1.00
Regulatory interactions governing the proliferation of T cell subsets stimulated with pokeweed mitogen. J Immunol (1984) 1.00
Recognition of hapten-modified cells in vitro by human T-lymphocytes. J Clin Invest (1979) 0.99
Mechanism of action of macrophage-derived suppressor factor produced by soluble immune response suppressor-treated macrophages. J Immunol (1981) 0.98
Mitochondrial modulation of maternally transmitted antigen: analysis of cell hybrids. Proc Natl Acad Sci U S A (1985) 0.98
Regulatory mechanisms in cell-mediated immune responses. VI. Interaction of H-2 and non-H-2 genes in elaboration of mixed leukocyte reaction suppressor factor. J Exp Med (1977) 0.98
Haplotype-specific suppression of antibody responses in vitro. I. Generation of genetically restricted suppressor T cells by neonatal treatment with semiallogeneic spleen cells. J Exp Med (1981) 0.98
Development of primary M, G, and A anti-TNP plaque-forming cell responses in vitro. J Immunol (1973) 0.97
Clear cell adenocarcinoma arising from a urethral diverticulum. J Urol (1995) 0.97
Primary in vitro immunogenicity of liposomal model membranes in mouse spleen cell cultures. J Immunol (1979) 0.97
Cell-mediated immune responses in vitro. II. Simultaneous generation of cytotoxic lymphocyte responses to two sets of alloantigens of limited cross-reactivity. J Immunol (1975) 0.96
H2-M3wt-restricted, Listeria monocytogenes-specific CD8 T cells recognize a novel, hydrophobic, protease-resistant, periodate-sensitive antigen. Int Immunol (1996) 0.95
Isolation and characterization of a novel streptococcal superantigen. Trans Assoc Am Physicians (1992) 0.95
Suppressor T cells as regulators of lymphocyte functions. Ann N Y Acad Sci (1975) 0.95
Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells. J Immunol (1977) 0.94
Inhibition of interferon or soluble immune response suppressor (SIRS) mediated suppression by levamisole. Int J Immunopharmacol (1983) 0.94
Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution. Clin Exp Immunol (1971) 0.94
Scanning electron microscopy of normal and mitogen-stimulated mouse lymphoid cells. Cell Immunol (1975) 0.94